Lidholm Jonas, Ballmer-Weber Barbara K, Mari Adriano, Vieths Stefan
Phadia AB, Research & Development Department, Uppsala, Sweden.
Curr Opin Allergy Clin Immunol. 2006 Jun;6(3):234-40. doi: 10.1097/01.all.0000225166.90768.d6.
The purpose of this paper is to review and discuss recent studies on component-resolved diagnostics in food allergy, involving panels of pure allergen molecules or arrays of peptides derived from allergen sequences, and to summarize the reporting of new food allergens during the past 2 years.
Several component-resolved diagnostic studies in food allergy suggest that the use of panels of allergen molecules may allow refined clinical information to be obtained on the likelihood or severity of an allergic food reaction and regarding diagnostic specificity. Further, in some studies the use of pure allergen molecules has led to a clearly higher sensitivity of the immunoglobulin E immunoassay compared with conventional allergen extracts.
While common diagnostic methods in allergy assess the presence or absence of allergen-specific sensitization, to date, no in-vitro or in-vivo test exists which exhibits full correlation with clinical food allergy. A multitude of recently reported findings and observations indicate that molecular analysis of allergen sensitization pattern may serve to enhance the clinical utility of immunoglobulin E antibody-based allergy diagnostics. Pure natural and recombinant allergen molecules as well as panels of synthetic peptides have been used for this purpose.
本文旨在回顾和讨论食物过敏中组分分辨诊断的近期研究,这些研究涉及纯过敏原分子面板或源自过敏原序列的肽阵列,并总结过去两年中新食物过敏原的报告情况。
食物过敏中的多项组分分辨诊断研究表明,使用过敏原分子面板可能有助于获取有关食物过敏反应可能性或严重程度以及诊断特异性的精确临床信息。此外,在一些研究中,与传统过敏原提取物相比,使用纯过敏原分子可使免疫球蛋白E免疫测定的灵敏度明显更高。
虽然过敏症的常见诊断方法评估的是是否存在过敏原特异性致敏,但迄今为止,尚无任何体外或体内测试与临床食物过敏完全相关。最近报道的大量发现和观察结果表明,过敏原致敏模式的分子分析可能有助于提高基于免疫球蛋白E抗体的过敏诊断的临床效用。为此已使用了纯天然和重组过敏原分子以及合成肽面板。